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ABSTRACT 
Short-chain fructooligosaccharides (scFOS) and galactooligosaccharides (GOS) are 
non-digestible oligosaccharides that result in a prebiotic effect in some animal species; 
however, the cat has not been well studied in this regard.  This experiment evaluated scFOS 
and GOS supplementation on nutrient digestibility, fermentative end-product production, 
and fecal microbial ecology of cats.  Eight healthy adult cats were fed diets containing no 
prebiotic, 0.5% scFOS, 0.5% GOS, or 0.5% scFOS + 0.5% GOS (scFOS+GOS) in a 
replicated 4x4 Latin square design.  Apparent total tract crude protein digestibility was 
decreased (P < 0.05) when cats were fed a diet containing scFOS + GOS compared to the 
other treatments.  Dry matter, OM, acid hydrolyzed fat, and GE digestibilities were not 
different among treatments.  Cats fed scFOS-, GOS-, and scFOS+GOS-supplemented diets 
had greater (P < 0.05) fecal Bifidobacterium spp. populations compared to cats fed the 
control diet.  Fecal pH was lower (P < 0.05) for cats fed the scFOS+GOS-supplemented diet 
compared to the control.  Butyrate (P = 0.05) and valerate (P < 0.05) concentrations were 
higher when cats consumed the scFOS+GOS diet.  Acetate tended to be greater (P = 0.10) 
when cats were fed the scFOS+GOS diet.  Total SCFA (P = 0.06) and total BCFA (P = 0.06) 
concentrations also tended to be greater when cats consumed the scFOS+GOS treatment.  
Fecal protein catabolites, including ammonia, 4-methylphenol, indole, and biogenic amines, 
did not differ among treatments, nor did blood lymphocytes, neutrophils, or total white 
blood cell counts, or fecal DM concentration and output.  Low level supplementation of 
scFOS, GOS, and their combination exert positive effects on select indices of gut health in 
cats. 
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CHAPTER 1 
INTRODUCTION 
Prebiotics are non-digestible food ingredients that modify the microbial ecology of 
the colon and improve indices of host health (Gibson and Roberfroid, 1995).  Many non-
digestible oligosaccharides (NDO) are resistant to enzymatic hydrolysis in the 
gastrointestinal tract, are fermented by the intestinal microflora, and selectively stimulate the 
growth and/or activity of one or more intestinal bacteria.  Galactooligosaccharides are a 
mixture of oligomers synthesized from lactose and consist of 2 - 8 saccharide units.  Tzotzis 
and Vulevic (2009) noted that GOS meets all of the criteria of a true prebiotic.  Short-chain 
fructooligosaccharides, a mixture of short-chain glucose and fructose monomers, have been 
widely studied in humans (Roberfroid, 2007) and dogs (Flickinger et al., 2003; Middelbos et 
al., 2007; Barry et al., 2009); however, few studies have been done in cats to date (Sparkes 
et al., 1998; Hesta et al., 2001; Barry et al., 2010). 
The colonic microbiota can play an important role in host animal health.  
Bifidobacterium spp. and Lactobacillus spp. are desirable bacterial species because of their 
beneficial effects, including inhibition of pathogenic bacteria (e.g., Clostridium spp.) and 
improving host immunity.  Cats supplemented with 175 mg lactosucrose/d (Terada et al., 
1993), 0.75% oligofructose (Sparkes et al., 1998), or 4% oligofructose (Barry et al., 2010) 
had modified colonic microbial populations compared to an oligosaccharide-free control. 
In the canine, low level inclusion of scFOS or inulin (0.2 and 0.4% of diet) increased 
ileal nutrient digestibility with no effect on fecal quality or microbial ecology of the colon, 
whereas dogs fed an inulin-supplemented diet tended to have increased total tract crude 
protein digestibility (Barry et al., 2009).  The moderate to high inclusion levels of inulin-
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type fructans were noted to lower total tract crude protein digestibility by dogs (Middelbos 
et al., 2007) and cats (Hesta et al., 2001).  This reduction may have resulted from the higher 
fecal bacterial mass produced in response to oligosaccharide supplementation.   
Cats nearly always are provided with more protein than is required to meet amino 
acid requirements.  This leads to an active population of clostridial species throughout the 
gastrointestinal tract of cats.  Clostridia are the major microbial species that use amino acids 
as fermentative substrates.  Consequently, several putrefactive compounds, including 
ammonia, biogenic amines, branched-chain fatty acids (BCFA), indole, phenol, and sulfur-
containing compounds, are produced.  The large quantities of putrefactive compounds may 
play an important role in causing disease of the large bowel, including colorectal cancer 
(Johnson, 1977).  The objective of this study was to determine the effects of low level 
prebiotic inclusion (0.5% scFOS, 0.5% GOS, and 0.5% scFOS + 0.5% GOS) on nutrient 
digestibility, fermentative metabolite concentrations, and large bowel microbial ecology of 
healthy adult cats. 
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CHAPTER 2 
LITERATURE REVIEW 
Introduction  
Since the potential health benefits of prebiotics were first described by Gibson and 
Roberfroid (1995), these compounds have been of interest to both the human and animal 
food industries.  Many non-digestible oligosaccharides (NDO), including inulin-type 
fructans, lactosucrose, lactulose, xylooligosaccharides (XOS), mannanoligosaccharides 
(MOS), and isomaltooligosaccharides (IMO), have prebiotic properties in dogs (Terada et 
al., 1992; Strickling et al., 2000; Beynen et al., 2001; Swanson et al., 2002a; Hesta et al., 
2003; Middelbos et al., 2007; Barry et al., 2009); however, only inulin-type fructans, 
galactooligosaccharides (GOS), and lactulose are proven prebiotics (Roberfroid, 2007b).   
Inulin-type fructans and GOS are commonly studied as functional food ingredients 
that improve human health.  Ingestion of inulin-type fructans and GOS selectively stimulate 
growth of beneficial Bifidobacterium spp. in the colon.  By producing acetate and lactate, 
Bifidobacterium spp. decrease luminal pH and create an unfavorable environment for 
growth of pathogenic bacteria.  Clinical benefits include blood sugar attenuation and lipid 
regulation, reduction of colon cancer risk, laxation, inhibition of diarrhea, fatty liver disease 
prevention, inflammatory bowel disease treatment, an increase in absorption of minerals, 
and improvement in immune function (Roberfroid, 2007a; Kelly, 2009; Tzortzis and 
Vulevic, 2009).  Beneficial effects of prebiotics, including inulin-type fructans and GOS, 
reported in humans are expected to occur in dogs and cats due to similarities in their 
digestive physiology and microbial ecology of the large bowel.  Therefore, the objective of 
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this literature review was to evaluate use of prebiotics and their potential benefits in 
companion animal diets. 
Prebiotics 
A prebiotic is a non-digestible food ingredient that beneficially affects the host by 
selectively stimulating the growth and/or activity of one or a limited number of bacteria in 
the large intestine, and thus improves host health (Gibson and Roberfroid, 1995).  Due to 
such effects, prebiotics must be resistant to enzymatic digestion and absorption in the 
gastrointestinal tract and must be fermented by intestinal bacteria (Roberfroid, 2007b).  
Non-digestible carbohydrates (oligo- and polysaccharides) are candidate prebiotics because 
they are not hydrolyzed by digestive enzymes or absorbed in the small intestine.  However, 
not all non-digestible carbohydrates are classified as prebiotics because they do not lead to 
changes in bacterial populations (Gibson and Roberfroid, 1995; Roberfroid, 2007b).  Among 
oligosaccharides, inulin-type fructans, GOS, and lactulose (Roberfroid, 2007b; Tzortzis and 
Velevic, 2009) are proven prebiotics due to their fulfillment of the classification criteria. 
Inulin-type fructans and short-chain fructooligosaccharides (scFOS) 
Inulin-type fructans are β-(2-1) linear fructans naturally found in several fruits and 
vegetables including wheat, onion, banana, garlic, and leek (Roberfroid, 2007a).  
Chemically, inulin-type fructans are linear polydisperse carbohydrates consisting of β-(2-1) 
fructosyl-fructose glycosidic linkages.  Some of these molecules have a glucose unit as the 
initial moiety.  Native chicory inulin is produced from hot water extraction of fresh chicory 
roots (De Leenheer, 1996).  The degree of polymerization (DP) is between 2 to 
approximately 60 units and the average DP (DPav) is 12 units.  Oligofructose, obtained from 
chicory inulin by partial enzymatic hydrolysis using endoinulinase (EC 3.2.1.7), is a mixture 
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of fructose chains [fructopyranosyl-(fructofuranosyl)n fructose; (FpyFn)] and contains a 
fructose chain with a terminal glucose [glucopyranosyl-(fructofuranosyl)n fructose; (GpyFn)] 
in which the DP varies from 2 to 7 with a DPav of 4.  Additionally, oligofructose can be 
obtained by enzymatic synthesis (transfructosylation) using the fungal enzyme, β-
fructosidase (EC 3.2.1.7), from Aspergillus niger.  In that process, sucrose is used as the 
starting substrate to which 1, 2, or 3 additional fructose units are linked by forming new β-
(2-1) linkages.  Therefore, this synthetic compound consists of only fructose chains with 
terminal glucose units (GpyFn) and varies in DP between 2 to 4 with a DPav of 3.6.  High 
molecular weight inulin-type fructan (inulin HP) is a mixture of GpyFn with 10 to 60 DP 
(DPav = 25) that results from a physical separation technique eliminating the oligomers with 
DP < 10 from native inulin.  A mixture of 30% oligofructose and 70% inulin HP is termed 
“oligofructose-enriched inulin” (Roberfroid, 2007a). 
Short-chain fructooligosaccharides (scFOS), short chain lengths of synthetic β-(2-1) 
linear fructans, are synonymous with oligofructose (Roberfroid, 2007a).  Short-chain FOS is 
the mixture of inulin-type oligomers synthesized from sucrose.  For this mixture, scFOS 
have GpyFn structures with a maximum DP (DPmax) of less than 10.  Because of the β-(2-1) 
linkages in the fructose monomers, inulin and scFOS resist hydrolysis by mammalian 
enzymes in the small intestine and are fermented by bacteria in the colon (Gibson and 
Roberfroid, 1995; Roberfroid, 2007a).   
Galactooligosaccharides 
 Galactooligosaccharides are a mixture of NDO produced from lactose consisting of 
between two and eight saccharide units.  These units always have glucose as the terminal 
unit and the remaining units are galactose and disaccharides comprised of two units of 
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galactose (Tzortzis and Vulevic, 2009).  Galactooligosaccharides are synthesized from 
lactose by the transgalactosylation activity of β-galactosidases.  The oligosaccharide 
composition varies among GOS mixtures depending on origin of the β-galactosidases.       
6′-galactosyllactose, which has β-(1-6) glycosidic bonds between two galactose monomers, 
is the main product when yeast β-galactosidase (from Kluyeveromyces subsp. lactis or K. 
fragilis) is used.  Enzymes derived from Bacillus circulans or Cryptococcus laurentii form 
mainly 4′-galactosyllactose.  Enzymes derived from Aspergillus oryzae mainly form 3′- and 
6′-galactosyllactose.  The main products of GOS are trisaccharides (4′- or 6′- 
galactosyllactose) and longer oligosaccharides consisting of 4 or more monosaccharide units 
(Sako et al., 1999).  
Infants fed breast milk have higher fecal Bifidobacterium spp. and lower fecal 
Clostridium spp. and Enterococcus spp. populations compared to infants fed cow’s milk.  
Among the variety of different oligosaccharides in human milk, lactose-derived 
oligosaccharides have been found in large quantities (Tzortzis and Vulevic, 2009). Rycroft 
et al. (2001) studied the effects of FOS and GOS on intestinal microflora in vitro using 
human fecal inoculum.  Both FOS and GOS increased the number of Bifidobacterium spp. 
and GOS decreased Clostridium spp. populations.  A “Measure of Prebiotic Effect (MPE)” 
was created to evaluate prebiotic efficacy in vitro (Vulevic et al., 2004).  The rate of 
substrate assimilation, the change in bacterial populations, and the ratio of lactate : total 
short-chain fatty acids (SCFA) produced were accounted for in the equation to compute the 
MPE value.  At 1% w/v, GOS had the highest MPE value, suggesting that it was the most 
robust prebiotic of all substrates tested.  In vivo, fecal Bifidobacterium spp. concentrations 
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were increased in healthy adult populations when fed GOS and various GOS mixtures (Ito et 
al., 1993; Tanaka et al., 1993; Gopal et al., 2003). 
Prebiotic effects in dogs and cats 
Supplementation of NDO can result in beneficial effects in companion animals.  
Ingestion of NDO selectively stimulates the growth of Bifidobacterium spp. in the colon.  
By producing acetate and lactate, Bifidobacterium spp. decrease luminal pH, creating an 
unfavorable environment for pathogenic bacteria.  During NDO fermentation, SCFA are 
produced.  Butyrate plays an important role as an energy source for colonocytes and helps 
prevent bacterial translocation by increasing gut integrity (Macfarlane and Cumming, 1991).  
Jacob (2007) noted that other beneficial effects include immune system modulation, 
laxation, reduction of protein catabolite production as a result of amino acid fermentation in 
the large bowel, and therapeutic roles in diabetes mellitus, lipid metabolism, liver disease, 
and chronic renal failure. 
 Stool characteristics.  Dietary fiber can increase fecal bulk by increasing fiber 
residues, fecal water, bacterial cell mass, or a combination of the three (Diez et al., 1997).  
However, low level inclusion of NDO may not affect fecal consistency or production.  Barry 
et al. (2009) fed five ileal cannulated adult female hounds with either an oligosaccharide-
free diet, inulin (0.2 and 0.4 %), or scFOS (0.2 and 0.4%) to determine their effects on 
nutrient digestion, stool metabolite concentrations, and microbiota populations.  Fecal score 
was not affected by treatment.   
Short-chain fructooligosaccharides and yeast cell wall (YCW; source of 
mannanoligosaccharides) were tested as potential replacements for traditional dietary fiber 
sources in dog diets (Middelbos et al., 2007).  Six ileal cannulated adult female hounds were 
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fed 1) control diet (no fermentable carbohydrate supplementation); 2) as (1) + 2.5% 
cellulose (low fermentable fiber); 3) as (1) + 2.5% beet pulp (moderately fermentable fiber); 
4) as (1) + 1% cellulose + 1.5% scFOS (CF); 5) as (1) + 1% cellulose + 1.2% scFOS + 0.3% 
YCW (CFY1), or 6) as (1) + 1% cellulose + 0.9% scFOS + 0.6% YCW (CFY2).  Fecal 
consistency of dogs fed CF, CFY1, or CFY2 was not affected by treatment.   
Flickinger et al. (2000) evaluated the effect of indigestible oligosaccharides (alpha-
glucooligosaccharides and maltodextrin-like OS) on stool characteristics.  Six ileal 
cannulated female adult hounds were fed either 1) an enteral formula diet (control); 2) as (1) 
+ 6% alpha-glucooligosaccharides; 3) as (1) + 6% maltodextrin.  Dogs supplemented with 
diet 2 had softer feces (P < 0.05) and greater fecal output (64.8 vs. 35.0 g/d; P < 0.05) 
compared to the control. 
Diez et al. (1998) evaluated the effects of three fibers (sugar beet fiber, guar gum, 
and inulin) supplemented to the basal diet of adult healthy beagles at 7% (as-is basis).  As 
compared to the control, dogs supplemented with 7% inulin excreted more wet feces (96.0 
vs. 65.6 g/d; P < 0.05), and had lower (P < 0.05) fecal DM percentages (27.0 vs. 34.4%).   
Hesta et al. (2001) fed adult cats diets containing 0, 3, 6, or 9% oligofructose. Fecal 
moisture percentage was greater (P < 0.01) for cats fed 6% (73.7%) or 9% (75.5%) 
oligofructose compared to 0% (69.3%) or 3% (70.9%) concentrations.  Cats fed 9% 
oligofructose (P < 0.05) excreted more feces per day (as-is basis; 31.9 g/d) compared to 0% 
(22.9 g/d) or 3% (22.2 g/d) oligofructose treatments.   
In a subsequent experiment, Hesta et al. (2001) fed cats diets containing inulin (0, 3, 
or 6% of the diet) or 3% oligofructose.  Cats fed a 6% inulin-supplemented diet excreted 
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feces with greater (P < 0.05) fecal moisture (74.8%) compared to 0% and 3% inulin 
treatments (70.1 and 71.1 %, respectively).   
Barry et al. (2010) fed healthy adult cats diets containing 4% oligofructose, 4% 
pectin, or 4% cellulose (as the control) in order to determine their effects on fecal protein 
catabolites and microbial populations.  Fecal scores were greater (P < 0.01) in cats fed the 
4% oligofructose-supplemented diet (2.8, softer feces) compared to the 4% cellulose diet 
(2.0), whereas fecal DM percentage and output were not affected.  Data from these studies 
suggest that high inclusion levels alter fecal consistency in cats.  Supplementation at the 0.5 
- 1% level is recommended for optimal stool quality (Hesta et al., 2001). 
During carbohydrate fermentation, fecal pH will be decreased as a result of SCFA 
and lactic acid production.  Cats supplemented with 175 mg/d lactosucrose (0.12% of diet) 
had numerically lower fecal pH (6.1) compared to no supplementation (6.3) after 14 d of 
administration (Terada et al., 1993).  Fecal pH was lower (P < 0.01) for cats fed diets 
supplemented with 6% (6.0) or 9% (5.7) oligofructose compared to cat fed 0% (6.4) or 3% 
(6.2) oligofructose (Hesta et al., 2001).  However, 3 and 6% inulin (Hesta et al., 2001) or 4% 
scFOS (Barry et al., 2010) supplementation did not change fecal pH compared to control in 
cats. 
Microbial ecology of the large intestine.  The colonic microbiota play an important 
role in host animal health.  Bifidobacterium spp. and Lactobacillus spp. are desirable 
bacterial species because of their beneficial effects, including inhibition of pathogenic 
bacterial (e.g., Clostridium spp.) growth and improving host immunity (Gibson and 
Roberfroid, 1995; Roberfroid, 2007a).  Lower gastrointestinal tract pH as a result of lactate 
production creates an unfavorable environment for several pathogenic bacterial species.  
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Human studies reported that metabolic end-products resulting from carbohydrate 
fermentation (lactate and acetate) inhibited growth of gram-positive and gram-negative 
pathogenic bacteria (Gibson and Wang, 1994).  The other benefits of Bifidobacterium spp. 
to the host include B vitamin synthesis, immune modulation, and blood ammonia reduction 
(Gibson and Roberfroid, 1995).   
To evaluate bifidogenic effects in adult cats, Sparkes et al. (1998) studied the effect 
of 0.75% oligofructose on fecal microflora.  As compared to no supplementation, fecal 
concentrations of Lactobacillus spp. (6.3 vs. 5.7 log10 cfu/g fecal DM) and Bacteroides spp. 
(9.5 vs. 8.0 log10 cfu/g fecal DM) were greater (P < 0.05).  However, fecal concentrations of 
Escherichia coli were lower (6.3 vs. 7.5 log10 cfu/g fecal DM; P < 0.05), whereas 
Clostridium perfringens (4.9 vs. 6.6 log10 cfu/g fecal DM) tended to be lower (P < 0.10).  
Terada et al. (1993) reported that adult cats supplemented with 175 mg lactosucrose/d had 
higher (P < 0.05) fecal Bifidobacterium spp. and Lactobacillus spp. and lower (P < 0.05) 
fecal Bacteroides spp. and Clostridium spp. populations compared to no supplementation at 
7 and 14 d of supplementation.  In the study of Barry et al. (2010), fecal concentrations of 
Bifidobacterium spp. were greater (11.6 vs. 10.4 log10 cfu/g fecal DM, P < 0.01) in cats fed a 
4% oligofructose-supplemented diet compared to a 4% cellulose-supplemented diet, 
whereas fecal concentrations of E. coli were lower (8.4 vs. 9.3 log10 cfu/g fecal DM, P < 
0.01).  
In dogs, the effect of prebiotics on canine microbiota concentrations were studied but 
with inconsistent results.  Swanson et al. (2002a) conducted two experiments testing effects 
of scFOS and (or) Lactobacillus acidophilus supplementation of adult dogs.  Dogs were 
supplemented orally via gelatin capsules with: 1) 2 g sucrose + 80 mg cellulose (as the 
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control); 2) 2 g FOS + 80 mg cellulose; 3) 1x10
9
 cfu LAC + 80 mg cellulose, or 4) 2 g FOS 
+ 1x10
9
 cfu LAC twice daily.  In the first experiment, fecal concentrations of C. perfringens 
tended (P < 0.10) to be lower in dogs supplemented with scFOS (9.6 log10 cfu/g fecal DM) 
compared to the control (9.9 log10 cfu/g fecal DM), whereas fecal concentrations of 
Bifidobacterium and Lactobacillus spp. were not affected.  In the second experiment, dogs 
supplemented with scFOS had greater fecal concentrations of Bifidobacterium spp. (9.9 vs. 
9.4 log10 cfu/g fecal DM; P < 0.05) and Lactobacillus spp. (9.8 vs. 9.1 log10 cfu/g fecal DM; 
P < 0.10), whereas fecal concentrations of C. perfringens were not affected.  In another 
study, Swanson et al. (2002c) supplemented adult dogs twice daily with 2 g scFOS + 1 g 
MOS or 2 g sucrose (as the control).  Dogs fed the scFOS+MOS-supplemented diet had 
greater (P < 0.05) fecal concentrations of Lactobacillus spp. in ileal effluent (8.7 vs. 7.6 
log10 cfu/g fecal DM) and feces (9.8 vs. 8.3 log10 cfu/g fecal DM) compared to the control.  
Fecal Bifidobacterium spp. concentrations were greater (P < 0.05) in dogs supplemented 
with scFOS+MOS (10.0 log10 cfu/g fecal DM) compared to the control (9.4 log10 cfu/g fecal 
DM); however, fecal concentrations of C. perfringens and E. coli were not affected. 
Flickinger et al. (2003) fed sixteen adult female hounds a corn-based diet 
supplemented with 0 or 1.9 g oligofructose/d.  Fecal concentrations of Bifidobacterium spp. 
concentrations were not affected by oligofructose supplementation.  In a subsequent study, 
ileal cannulated adult female hounds were fed a meat-based kibble diet supplemented with 
0, 1, 2, or 3 g scFOS/d via gelatin capsule.  Short-chain fructooligosaccharides linearly 
increased (P < 0.05) fecal populations of total aerobes (8.5, 8.7, 8.9, and 9.3 log10 cfu/g fecal 
DM, respectively) and linearly decreased (P < 0.05) fecal C. perfringens (10.0, 10.0, 9.8, 
and 9.7 log10 cfu/g fecal DM, respectively) compared to the control.   
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Middelbos et al. (2007) found that dogs fed a 1% cellulose + 1.5% scFOS-
supplemented diet had greater (P < 0.05) fecal concentrations of Bifidobacterium spp. (8.7 
vs. 7.7 log10 cfu/g fecal DM) and Lactobacillus spp. (12.2 vs. 11.3 log10 cfu/g fecal DM) 
compared to dogs fed a 2.5% cellulose diet.   
Barry et al. (2009) fed dogs low-level additions of scFOS or inulin (0.2 and 0.4% of 
diet).  Colonic microbial populations were not affected by treatments.   
Data from these studies support the bifidogenic effect of inulin-type fructans, MOS, 
and (or) lactosucrose in dogs and cats.  However, magnitude of response varies depending 
on a host of conditions, some of which can be controlled and some of which cannot. 
 Short-chain fatty acids (SCFA).  Bacterial fermentation of carbohydrates produces 
SCFA and gases, including methane, carbon dioxide, and hydrogen (Macfarlane and 
Cumming, 1991).  The main SCFA are acetate, propionate, and butyrate.  Butyrate, a major 
energy source of colonocytes, plays an important role in gastrointestinal tract health by 
regulating the balance of cell maturation, cell differentiation, and apoptosis (Blottiére et al., 
2003).   
Hesta et al. (2001) noted that fecal total SCFA concentrations were greater (P < 0.05) 
in cats fed a 6% inulin-supplemented diet (7632 μmol/d) compared to control-fed cats (4329 
μmol/d).  Cats fed a diet supplemented with 3% oligofructose had numerically greater total 
SCFA (5892 μmol/d) compared to cats fed a control (4329 μmol/d) and a 3% inulin-
supplemented diet (5116 μmol/d).  Barry et al. (2010) noted that cats fed a 4% oligofructose-
supplemented diet had greater (P < 0.01) fecal butyrate concentrations compared to those 
fed a 4% cellulose-supplemented diet (97.3 vs. 39.2 μmol/g fecal DM). 
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In dogs, oral supplementation of 1, 2, or 3 g/d scFOS did not change fecal 
concentrations of SCFA.  In the same study, dogs fed 1.9 g/d hydrolyzed inulin 
(oligofructose) had greater (P < 0.05) fecal concentrations of propionate (31.5 vs. 20.3 
mmol/g fecal DM), whereas fecal total SCFA concentrations tended (P < 0.10) to be greater 
(82.7 vs. 63.1 mmol/g fecal DM) compared to the control (Flickinger et al., 2003).  Swanson 
et al. (2002a) noted that a diet supplemented with 4 g scFOS/d increased fecal 
concentrations of lactate (41.7 vs. 2.7 μmol/g fecal DM; P < 0.05), propionate (119.6 vs. 
83.6 μmol/g fecal DM; P < 0.05), and butyrate (58.2 vs. 40.8 μmol/g fecal DM; P < 0.10) 
compared to the control diet fed to adult dogs.  In another experiment, fecal concentrations 
of butyrate (63.4 vs. 48.2 μmol/g fecal DM; P < 0.05) and lactate (70.2 vs. 17.3 μmol/g fecal 
DM; P < 0.10) were greater in dogs fed a scFOS-supplemented diet compared to a control 
(Swanson et al., 2002a).  
Propst et al. (2003) fed adult hounds kibble diets supplemented with 0, 0.3, 0.6, or 
0.9% oligofructose and inulin (as-is basis).  Compared to the control, fecal concentrations of 
acetate (348.9, 358.0, and 382.8 vs. 274.6 μmol/g fecal DM), propionate (127.1, 129.1, and 
132.1 vs. 92.7 μmol/g fecal DM), butyrate (53.9, 51.2, and 53.3 vs. 39.2 μmol/g fecal DM), 
and total SCFA (529.9, 538.3, and 568.8 vs. 406.4 μmol/g fecal DM) were increased linearly 
(P < 0.05) in dogs supplemented with oligofructose.  In the same study, dogs supplemented 
with inulin had a linear increase (P < 0.05) in fecal concentrations of propionate (110.6, 
111.2, and 109.7 vs. 92.7 μmol/g fecal DM) and butyrate (45.5, 46.5, and 48.4 vs. 39.2 
μmol/g fecal DM).  Middelbos et al. (2007) noted that fecal butyrate concentrations were 
greater (P < 0.05) in dogs fed a 1% cellulose + 1.5% scFOS-supplemented diet (40 μmol/g 
fecal DM) compared to a 0% cellulose (28 μmol/g fecal DM) and 2.5% cellulose-
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supplemented diet (21 μmol/g fecal DM).  Barry et al. (2009) noted that a quadratic increase 
(P < 0.05) in fecal butyrate concentrations occurred in dogs fed 0.2 and 0.4% scFOS-
supplemented diets (63.3 and 40.2 μmol/g fecal DM) compared to the control (40.1 μmol/g 
fecal DM).  Data presented from these studies provide evidence that low level inclusion of 
prebiotic can increase fecal SCFA concentrations in dogs and cats. 
 Fecal odor components.  Substances resulting from fermentation by proteolytic 
bacteria of both endogenous and undigested protein influence fecal malodor.  These 
putrefactive compounds include ammonia, aliphatic amines (e.g., agmatine, cadavarine, 
histamine, phenylethylamine, putrescine, and tyramine), branched-chain fatty acids (e.g., 
isobutyrate and isovalerate), phenols (e.g., phenol, p-cresol, and 4-ethylphenol), indoles 
(e.g., indole, 3-methylindole, 2-methylindole, 2,3-methylindole, 2,5-methylindole, and 5-
chloroindole), and volatile sulfur–containing compounds (e.g., dimethyl disulfide, diethyl 
disulfide, and di-n-butyl disulfide) (Hussein, 1998). 
Cats and dogs ingest more protein than the requirement to enhance diet digestibility.  
This leads to an active population of clostridial species throughout the gastrointestinal tract.  
Lubbs et al. (2008) noted that C. perfringens populations were greater (12.39 vs. 10.83 
cfu/g; P < 0.05) in cats fed a high protein diet (approximately 50% of diet) compared to a 
moderate protein diet (approximately 30% of diet).  Because Clostridium spp. are the one of 
major microbiota that use amino acids as fermentative substrates (Macfarlane and 
Cummings, 1991), putrefactive compound concentrations are increased and become a 
critical concern in dog and cat health.  High concentrations of putrefactive compounds may 
play an important role in causing or exacerbating many types of cancer, including colorectal 
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cancer (Johnson, 1977).  Additionally, ammonia can stimulate and cause tumorogenesis (Lin 
and Visek, 1991). 
In cats, Terada et al. (1993) noted that after 7 and 14 d of 175 mg lactosucrose/d 
supplementation, fecal concentrations of ammonia (159.7 and 161.5 vs. 338.8 μg/g wet 
feces), ethylphenol (10.9 and 7.6 vs. 19.6 μg/g wet feces), and indole (17.8 and 29.7 vs. 48.3 
μg/g wet feces) were decreased (P < 0.05) compared to no supplementation.  Hesta et al. 
(2005) fed adult cats with a reduced protein diet (28.9% DM) supplemented with 
oligofructose (3.11% DM) or no oligofructose (as the control).  In this study, fecal 
concentrations of volatile sulfur-containing compounds were not different among dietary 
treatments.  However, Barry et al. (2010) noted that cats fed a 4% oligofructose-
supplemented diet had greater fecal concentrations of ammonia (0.2 vs. 0.1 μmol/g fecal 
DM; P < 0.01), indole (2.4 vs. 1.4 μmol/g fecal DM; P = 0.01), 4-methyl phenol (3.7 vs. 1.6 
μmol/g fecal DM; P < 0.01), isobutyrate (12.6 vs. 8.2 μmol/g fecal DM; P < 0.05), 
isovalerate (21.0 vs. 13.3 μmol/g fecal DM; P < 0.05), valerate (29.8 vs. 22.5 μmol/g fecal 
DM; P < 0.05), total BCFA (63.3 vs. 44.0 μmol/g fecal DM; P < 0.05), cadaverine (55.68 vs. 
15.26 μmol/g fecal DM; P < 0.01), putrescine (13.28 vs. 2.07 μmol/g fecal DM; P < 0.01), 
tryptamine (5.77 vs. 1.17 μmol/g fecal DM; P < 0.01), and total amines (76.10 vs. 20.69 
μmol/g fecal DM; P < 0.01) compared to cats fed a 4% cellulose control diet, whereas 
tyramine was lower (0.24 vs. 1.38 μmol/g fecal DM; P < 0.05)  The authors stated that these 
increases might be the result of rapid fermentation and absorption of the oligosaccharides in 
the proximal colon, with proteolytic bacteria continuing to ferment amino acids as an energy 
source to survive in the descending colon, resulting in greater fecal putrefactive compound 
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production.  Also in this study, these carbohydrates were the main dietary fiber sources 
rather than low level supplements as was the case for most of the previous studies. 
Swanson et al. (2002a) noted that 4 g scFOS/d-supplemented dogs had lower (P < 
0.01) fecal concentrations of isobutyrate (6.0 vs. 7.6 μmol/g fecal DM), isovalerate (9.8 vs. 
12.2 μmol/g fecal DM), and total BCFA (16.5 vs. 20.4 μmol/g fecal DM) compared to no 
supplementation.  Swanson and co-workers (2002b) supplemented adult dogs with 0 (no 
FOS or MOS), 1 g FOS, 1 g MOS, or 1g FOS + 1 g MOS twice daily via gelatin capsule.  
Dogs supplemented with 2 g/d FOS had lower (P < 0.05) fecal concentrations of total phenol 
and indole (1.50 μmol/g fecal DM) compared to no supplementation (3.03 μmol/g fecal 
DM).  Additionally, dogs supplemented with 1.9 g/d oligofructose tended (P = 0.06) to have 
lower fecal ammonia concentrations (2.0 mg/g fecal DM) compared to no supplementation 
(4.4 mg/g fecal DM) but not fecal BCFA and biogenic amine concentrations (Flickinger et 
al., 2003).  Barry et al. (2009) noted that dogs fed a scFOS (18.7 and 21.7 vs. 39.5 μmol/g 
fecal DM)- or inulin (38.15 and 15.7 vs. 39.5 μmol/g fecal DM)-supplemented diet (0.2 and 
0.4% of diet) had lower (P < 0.05) fecal phenol concentrations, but fecal biogenic amine 
concentrations were not affected. 
Nutrient digestibility.  The effects of inulin (3 and 6%, DM basis) and oligofructose 
(3%, DM basis) on nutrient digestibility by healthy adult cats were studied (Hesta et al., 
2001).  As compared to no supplementation, total tract crude protein digestibility was 
decreased (P < 0.01) in cats fed 3% (82.8 vs. 87.0%) and 6% (77.3 vs. 87.0%) inulin or 3% 
(83.1 vs. 87.0%) oligofructose.  Total tract fat digestibility was decreased (93.1, 90.1, and 
93.2%, respectively, vs. 96.1%; P < 0.01) in cats supplemented with either concentration of 
inulin or oligofructose compared to the control.  However, once the total tract crude protein 
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digestibility was corrected for bacterial nitrogen, no differences among treatments were 
noted.  In contrast, Barry et al. (2010) reported that 4% oligofructose supplementation 
(88.0%) did not affect total tract crude protein digestibility compared to the 4% cellulose 
treatment (90.5%) in cats.   
In dogs, total tract crude protein (84.9 vs. 86.9%) and total dietary fiber (15.3 vs. 
27.3%) digestibility values were lower (P < 0.05), but no difference in ileal digestibility was 
observed in dogs fed a 1.5% scFOS-supplemented diet compared to no supplementation 
(Middelbos et al., 2007).  Additionally, Flickinger et al. (2003) noted that dogs fed a 1.9 g/d 
oligofructose-supplemented diet had lower total tract OM (73.6 vs. 78.7%; P < 0.05), DM 
(79.2 vs. 83.0 %; P < 0.05), lipid (78.3 vs. 86.7 %; P < 0.01), and crude protein (78.4 vs. 
81.5%; P < 0.15) digestibility values compared to no supplementation.  The authors 
suggested that the decrease in nutrient digestibility resulted from faster intestinal transit time 
due to the presence of fermentable fiber in the diet.  The tendency for oligofructose to 
decrease total tract crude protein digestibility was due to an increase in fecal bacterial 
biomass.  Additionally, oligofructose might form a complex with dietary fat, thus, affecting 
lipid digestibility.  In the same study, Flickinger et al. (2003) noted that ileal digestibility of 
crude protein (59.4, 61.0, 68.9, and 72.0%) and lipid (92.3, 92.6, 93.9, and 94.7%) tended to 
be linearly increased (P < 0.10) with increasing scFOS concentration (0, 1, 2, and 3 g/d), but 
no trend was observed in total tract nutrient digestibility.  Barry et al. (2009) noted that ileal 
crude protein digestibility was linearly increased (P < 0.01) in dogs fed 0, 0.2, or 0.4 % 
inulin (78.4, 80.3, and 81.5%, respectively) and scFOS (78.4, 80.4, and 81.1%, 
respectively).  In the same study, total tract crude protein digestibility tended (P < 0.10) to 
be linearly increased in dogs supplemented with 0, 0.2, or 0.4% inulin (88.7, 88.9, and 
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89.6%, respectively); however, this response was not affected by scFOS supplementation.  
The authors hypothesized that peptide tyrosine tyrosine (PYY) affected intestinal transit 
time, thus affecting crude protein digestibility.  Short-chain fatty acid production stimulates 
PYY activity, delaying gastric emptying and increasing intestinal transit time, thereby 
leading to higher digestibility values.  Additionally, glucagon like peptide-1 (GLP-1) has 
been noted to increase intestinal transit time in response to fermentable substrate (ileal brake 
effect), resulting in greater digestibility coefficients.  
Mineral absorption.  Non-digestible oligosaccharides may stimulate apparent 
mineral absorption (Beynen et al., 2002).  It has been hypothesized that production of SCFA 
and lactate as a result of carbohydrate fermentation in the colon increases mineral solubility 
and absorption (Beynen et al., 2001).  The absorption of Ca, Mg, and Fe by rats was 
increased by oligofructose supplementation (Otha et al., 1995).  In dogs, the effect of 
lactulose on the apparent absorption of Ca and Mg was studied by Beynen et al. (2001).  Six 
healthy adult dogs were fed a diet containing either 0, 1, or 3 g lactulose/MJ metabolizable 
energy.  A linear increase (P < 0.05) in Ca (11.5, 18.7, and 21.1%, respectively) and Mg 
(23.3, 29.7, and 35.5%, respectively) absorption was noted.  Beynen et al. (2002) fed five 
dogs a dry food with either 1% w/w oligofructose or no supplementation (control).  Dogs 
fed 1% oligofructose had greater (P < 0.05) apparent Ca (16.0 vs. 8.6%) and Mg (23.4 vs. 
14.0%) absorption compared to the control.  However, P absorption was not affected 
because it is not sensitive to a pH change in the ileal digesta (Beynen et al., 2002).  Apparent 
absorption rates of Ca, P, Mg, Na, and K were not changed with 1g/kg BW (approximately 
5%) of transgalactooligosaccharides (TGOS), mannanoligosaccharides (MOS), lactose, or 
lactulose in adult dogs (Zentek et al., 2002).  
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Immune function.  Bifidobacterium spp. can act as immunomodulators (Gibson and 
Roberfroid, 1995) and may have many effects on immune function including mitogenic 
activity, promotion of macrophages, stimulation of antibody production, and anti-tumor 
effects (Bornet and Brouns, 2002).  Swanson et al. (2002b) noted that blood lymphocytes (as 
a percentage of total WBC) were greater (P < 0.05) in dogs fed a 2 g/d MOS-supplemented 
diet (16.8%) compared to no supplementation (15.6%), whereas ileal IgA concentrations 
were greater (P < 0.10) in dogs fed a combination of 2 g FOS/d + 2 g MOS/d (4.9 vs. 3.4 
mg/g DM or 12.22 vs. 8.22 mg/g crude protein). The authors suggested that this 
combination might increase local immunity and enhance protection against pathogens.  In 
another study, sixteen bitches at 35 d of gestation were fed 0 (control) or 1% scFOS 
(Adogony et al., 2006).  In this study, IgM concentrations in milk were consistently 
increased (P < 0.01) during lactation in bitches fed a 1% scFOS-supplemented diet 
compared to the control, while serum IgM was not increased in blood.  Additionally, from 
whelping to weaning, the same diets were fed ad libitum to the mother and her puppies.  At 
21 d of age, puppies were intranasally inoculated with a vaccine against Bordetella 
brochiseptica.  The concentrations of B. bronchiseptica-specific IgM were not significantly 
different between treatments (280.3 vs. 314.7 ng/ml). 
Middelbos et al. (2007) reported that there was no significant difference in white 
blood cell counts or ileal and blood Ig concentrations in dogs fed 1.5% scFOS or 
combinations of scFOS + YCW (1.2% + 0.3% or 0.9% + 0.6%) compared to no 
supplementation or to the 2.5% cellulose negative control treatment.  The authors stated that 
the higher supplement concentrations might be necessary to alter immunological indices.  
These data indicate that scFOS, YCW (MOS), and their combination may help promote 
 22 
 
systemic and local immune responses in dogs.  Due to inconsistent results, the proper 
inclusion level is not currently established.  There is no research regarding prebiotic effects 
on immune status of cats.  
Glucose metabolism.  Inulin-types fructans may regulate glycemia and insulinemia 
by delaying gastric emptying, increasing intestinal transit time, and decreasing hepatic 
gluconeogenenesis due to SCFA production, especially propionate, and/or stimulation of 
glycolysis (Roberfroid, 2007a).  Diez et al. (1997) fed dogs a corn-based diet supplemented 
with a blend of scFOS and sugar beet fiber (SBF) in a 4:1 ratio at 0, 5, or 10% (DM basis).  
Postprandial plasma glucose concentrations were lower (P < 0.01) in dogs fed the 8% FOS + 
2% SBF-supplemented diet compared to no supplementation, whereas preprandial plasma 
glucose concentrations were not affected.  Hesta et al. (2003) fed healthy adult dogs 1) a low 
fiber control diet; 2) a high fiber diet (HF); and 3) as (1) + 10% isomalto-oligosaccharides.  
Dogs fed diet 3 had lower postprandial plasma glucose concentrations at 20 (P < 0.01), 60 (P 
< 0.01), 90 (P = 0.05), 150 (P < 0.05), and 360 (P < 0.10) min after eating compared to the 
control.  Respondek et al. (2008) noted that the rate of glucose infusion was increased (P < 
0.05) in obese dogs supplemented with 1% scFOS during the euglycemic hyperinsulinemic 
clamp, suggesting a greater insulin sensitivity compared to the obese dogs fed the control 
diet (7.77 vs. 4.72 mg·kg
-1 
·min
-1
).  In the study of Verbrugghe et al. (2009), eight non-obese 
and eight obese cats were randomized and allotted to food (control extruded diet [46% CP, 
15% fat, and 27% carbohydrate] or control + 2.5% of a mixture of oligofructose and inulin).  
Glucose tolerance was not affected by treatment in healthy, normal weight or obese cats.  
The authors stated that the absence of an effect of inulin and oligofructose on glucose and 
insulin metabolism in cats might be explained by low carbohydrate concentrations compared 
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to dogs and to slow fermentation due to the relatively short large intestine and to the high 
degree of polymerization of the prebiotic tested.  Additionally, cats are prone to insulin 
resistance, especially obese cats; therefore, this unique feature of the carnivore might affect 
glucose and insulin responses.  However, greater propionylcarnitine (P = 0.03) and  lower 
methylmalonylcarnitine (P = 0.07) and aspartate amino transferase (P = 0.025) 
concentrations were observed in healthy, normal weight or obese cats fed 2.5% of a mixture 
of inulin and oligofructose, suggesting that they may help modulate glucose metabolism by 
inhibiting gluconeogenesis and amino acid catabolism.  Therefore, feeding 2.5% of a 
mixture of inulin and oligofructose may be helpful in treating feline insulin resistance and 
diabetes (Verbrugghe et al., 2009). 
Lipid metabolism.  Modulation of either the digestion/absorption or the metabolism 
of lipids may be impacted by inulin-type fructans, thus affecting blood triglyceride and 
cholesterol concentrations.  Inulin-type fructans may affect lipid homeostasis through 1) 
modification of glucose and/or insulin concentrations; 2) modification of macronutrient 
absorption by either delaying gastric emptying and (or) decreasing intestinal transit time; 3) 
increasing propionate, an inhibitor of fatty acid synthesis; 4) increasing concentrations of 
biogenic amines, especially putrescine; and 5) increasing production of enteroendocrine 
peptide (Roberfroid, 2007a).  Plasma triglyceride concentrations were reduced (P < 0.05) 
with 8% scFOS + 2% beet pulp supplementation during a 6 h postprandial period in non-
hyperlipidemic dogs, whereas prepandial triglycerides and cholesterol concentrations were 
lower (P < 0.05) compared to the control (Diez et al., 1997).  In the same study, 4% scFOS + 
1% beet pulp decreased (P < 0.05) preprandial triglyceride concentrations (Diez et al., 
1997).  However, Respondek et al. (2008) noted that 1% scFOS did not affect plasma 
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triglyceride and cholesterol concentrations after an overnight fast of obese dogs compared to 
the control.  The authors suggested that the lack of difference might be attributed to the low 
concentration of scFOS used or to the initial blood cholesterol concentrations.   
Nitrogen metabolism.  During oligosaccharide fermentation, intestinal bacteria 
require a N source for protein synthesis to maintain maximal bacterial growth.  
Consequently, blood urea N may be reduced by increased N diversion to the gastrointestinal 
tract.  This reduction may have benefits for renal patients.  Dogs fed a scFOS + beet fiber 
(4% + 1% or 8% + 2%, DM basis)-supplemented diet had lower (P < 0.05) pre- and 
postprandial plasma urea concentrations compared to control dogs (Diez et al., 1997).  Adult 
dogs fed diets containing 0, 1, or 3 g lactulose/MJ metabolizable energy exhibited linear 
increases (P = 0.13) in fecal N concentrations (0.86, 0.87, and 1.05 g/d), whereas urinary 
urea excretion was linearly decreased (264.6, 261.4, and 248.2 mmol/d; P < 0.05) (Beynen 
et al., 2001).  However, 1% w/w oligofructose supplementation did not affect fecal ammonia 
and urinary urea concentrations compared to the control (Beynen et al., 2002), perhaps due 
to low level supplementation. 
Fecal N excretion was greater (P < 0.05) when cats were fed a 2% inulin-
supplemented diet compared to a control, whereas the decrease in urinary N excretion was 
not observed (Groenveld et al., 2001). This study suggested that N balance was not altered 
by FOS supplementation.  Hesta et al. (2005) found that dogs fed 3.11% oligofructose in a 
lower protein diet (28.9%, DM basis) increased (P < 0.10) fecal N excretion in adult cats 
compared to no supplementation.  Supplementation of oligofructose also tended (P < 0.10) 
to increase fecal 
15
N excretion, and tended (P < 0.10) to decrease urinary 
15
N excretion 
compared to no supplementation.  The lower urinary N excretion might be explained by 1) 
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lower ammonia absorption due to lower luminal pH; 2) excess N used for bacterial protein 
synthesis; and/or 3) increased urea transport to the gut. 
Prebiotic mixtures 
Prebiotic mixtures, primarily inulin-type fructans combined with GOS, have been 
investigated in humans.  A galactooligosaccharide and inulin-type fructan (i.e., inulin HP) 
mixture (9:1) has been studied with the intent of mimicking, in part, the oligosaccharide 
composition found in human breast milk (Boehm and Moro, 2008).  Studies in pre-term and 
term infants have shown that a formula supplemented with this GOS/inulin HP prebiotic 
mixture results in an intestinal microbiota similar to that found in breast-fed infants.  Kelly 
(2009) noted that a GOS/inulin HP combination contributes to: 1) a reduction in the 
incidence of atopic disease; 2) a reduction in recurrent wheezing and allergic urticaria in 
infants from parents with a history of atopic disease; 3) a decrease in episodes of upper 
respiratory tract infections, fever, and antibiotic prescriptions; 4) a decrease in the incidence 
of acute diarrhea; 5) improved fecal consistency and stool frequency; 6) accelerated gastro-
intestinal transit time; 7) increased fecal secretory IgA; and 8) decreased bilirubin 
concentrations during the first 72 h of life in formula-fed infants. 
There are few studies testing prebiotic mixtures in dogs.  Swanson et al. (2002b) 
noted that a combination of 2 g scFOS/d + 2 g MOS/d increased (P < 0.10) ileal IgA 
concentrations and decreased (P < 0.05) fecal total indole and phenol concentrations 
compared to a prebiotic-free diet.  Swanson et al. (2002c) reported that 4 g scFOS/d + 2 g 
MOS/d tended (P < 0.10) to increase plasma lymphocytes (19.95%) compared to the control 
(17.29%), whereas ileal IgA, plasma IgA, IgG, and IgM, and fecal IgA concentrations were 
not different among treatments.  Therefore, dietary supplementation with scFOS+MOS may 
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have beneficial effects on colon health and immunity in dogs.  Middelbos et al. (2007) 
reported that a combination of 1.2% scFOS and 0.3% MOS in the diet increased (P < 0.05) 
fecal butyrate concentrations (41 vs. 21 μmol/g fecal DM) and fecal populations of 
Bifidobacterium spp. (9.1 vs. 7.8 cfu/g fecal DM), whereas total tract crude protein 
digestibility was decreased (84.7 vs. 86.7%; P < 0.05) compared to the oligosaccharide-free 
diet.  Dogs fed a combination of 0.9% scFOS and 0.6% MOS had greater (P < 0.05) fecal 
butyrate concentrations (42 vs. 21 μmol/g fecal DM) and fecal populations of 
Bifidobacterium spp. (8.7 vs. 7.8 cfu/g fecal DM) and Lactobacillus spp. (12.1 vs. 11.2 cfu/g 
fecal DM), whereas total tract crude protein digestibility was lower (84.8 vs. 86.7%; P < 
0.05) compared to the oligosaccharide-free treatment.  A combination of FOS and MOS may 
provide health benefits, including microbial modification, decreased putrefactive compound 
production, and (or) improved systemic and local immunity.  
Conclusion 
  Data presented in this literature review indicate that prebiotic supplementation has 
beneficial outcomes in dogs and cats.  The strongest beneficial effect is improvement in 
indices of gastrointestinal tract heath.  Studies showed increased fecal concentrations of 
beneficial bacteria (Bifidobacterium spp. and (or) Lactobacillus spp.) and SCFA (i.e., 
butyrate and (or) acetate), whereas fecal protein catabolite concentrations were almost 
always decreased.  Prebiotics also appear to modulate both local and systemic 
immunological indices in dogs, but with inconsistent results; however, no such study has 
been conducted in cats.  Low level prebiotic inclusion appears to improve nutrient 
digestibility and mineral absorption in dogs.  Only two studies evaluated the effects of 
fructans on nutrient digestibility in cats, and one study noted a decrease in total tract crude 
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protein and fat digestibility values when cats were supplemented with moderate to high 
concentrations of fructans.  Due to inconsistent results and limited studies, weak evidence 
for immunological and nutrient digestibility responses exist in cats.  The weakest data 
regarding prebiotic supplementation is that dealing with regulation of glucose, lipid, and N 
metabolism in dogs and cats, because these effects were evaluated only in normal dogs and 
cats as compared to those that were health-compromised. 
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CHAPTER 3 
EFFECTS OF SHORT-CHAIN FRUCTOOLIGOSACCHARIDES AND 
GALACTOOLIGOSACCHARIDES, INDIVIDUALLY AND IN COMBINATION, 
ON NUTRIENT DIGESTIBILITY, FECAL FERMENTATIVE METABOLITE 
CONCENTRATIONS, AND LARGE BOWEL MICROBIAL ECOLOGY OF 
HEALTHY ADULT CATS 
Abstract 
Short-chain fructooligosaccharides (scFOS) and galactooligosaccharides (GOS) are 
non-digestible oligosaccharides that result in a prebiotic effect in some animal species; 
however, the cat has not been well studied in this regard.  This experiment evaluated scFOS 
and GOS supplementation on nutrient digestibility, fermentative end-product production, 
fecal microbial ecology.  Eight healthy adult cats were fed diets containing no prebiotic, 
0.5% scFOS, 0.5% GOS, or 0.5% scFOS + 0.5% GOS (scFOS+GOS) in a replicated 4x4 
Latin square design.  Apparent total tract crude protein digestibility was decreased              
(P < 0.05) when cats were fed a diet containing scFOS + GOS compared to the other 
treatments.  Dry matter, OM, acid hydrolyzed fat, and GE digestibilities were not different 
among treatments.  Cats fed scFOS-, GOS-, and scFOS+GOS-supplemented diets had 
greater (P < 0.05) fecal Bifidobacterium spp. populations compared to cats fed the control 
diet.  Fecal pH was lower (P < 0.05) for cats fed the scFOS+GOS-supplemented diet 
compared to the control.  Butyrate (P = 0.05) and valerate (P < 0.05) concentrations were 
higher when cats consumed the scFOS+GOS diet.  Acetate tended to be greater (P = 0.10) 
when cats were fed the scFOS+GOS diet.  Total SCFA (P = 0.06) and total BCFA (P = 0.06) 
concentrations also tended to be greater when cats consumed the scFOS+GOS treatment.  
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Fecal protein catabolites, including ammonia, 4-methylphenol, indole, and biogenic amines, 
did not differ among treatments, nor did blood lymphocytes, neutrophils, or total white 
blood cell counts, or fecal DM concentration and output.  Low level supplementation of 
scFOS, GOS, and their combination exert positive effects on select indices of gut health in 
cats. 
Introduction 
Prebiotics are non-digestible food ingredients that modify the microbial ecology of 
the colon and improve indices of host health (Gibson and Roberfroid, 1995).  Many non-
digestible oligosaccharides (NDO) are resistant to enzymatic hydrolysis in the 
gastrointestinal tract, are fermented by the intestinal microflora, and selectively stimulate the 
growth and/or activity of one or more intestinal bacteria.  Galactooligosaccharides are a 
mixture of oligomers synthesized from lactose and consist of 2 - 8 saccharide units.  Tzotzis 
and Vulevic (2009) noted that GOS meets all of the criteria of a true prebiotic.  Short-chain 
fructooligosaccharides, a mixture of short-chain glucose and fructose monomers, have been 
widely studied in humans (Roberfroid, 2007) and dogs (Flickinger et al., 2003; Middelbos et 
al., 2007a; Barry et al., 2009); however, few studies have been done in cats to date (Sparkes 
et al., 1998; Hesta et al., 2001; Barry et al., 2010). 
The colonic microbiota can play an important role in host animal health.  
Bifidobacterium spp. and Lactobacillus spp. are desirable bacterial species because of their 
beneficial effects, including inhibition of pathogenic bacteria (e.g., Clostridium spp.) and 
improving host immunity.  Cats supplemented with 175 mg lactosucrose/d (Terada et al., 
1993), 0.75% oligofructose (Sparkes et al., 1998), or 4% oligofructose (Barry et al., 2010) 
had modified colonic microbial populations compared to oligosaccharide-free controls. 
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In the canine, low level inclusion of scFOS or inulin (0.2 and 0.4% of diet) increased 
ileal nutrient digestibility with no effect on fecal quality or microbial ecology of the colon, 
whereas dogs fed an inulin-supplemented diet tended to have increased total tract crude 
protein digestibility (Barry et al., 2009).  The moderate to high inclusion levels of inulin-
type fructans were noted to lower total tract crude protein digestibility by dogs (Middelbos 
et al., 2007a) and cats (Hesta et al., 2001).  This reduction may have resulted from the higher 
fecal bacterial mass produced in response to oligosaccharide supplementation. 
Cats nearly always are provided with more protein than is required to meet amino 
acid requirements.  This leads to an active population of clostridial species throughout the 
gastrointestinal tract of cats.  Clostridia are the major microbial species that use amino acids 
as fermentative substrates.  Consequently, several putrefactive compounds including 
ammonia, biogenic amines, branched-chain fatty acids (BCFA), indole, phenol, and sulfur-
containing compounds, are produced.  The large quantities of putrefactive compounds may 
play an important role in causing disease of the large bowel, including colorectal cancer 
(Johnson, 1977).  The objective of this study was to determine the effects of low level 
prebiotic inclusion (0.5% scFOS, 0.5% GOS, and 0.5% scFOS + 0.5% GOS) on nutrient 
digestibility, fermentative metabolite concentrations, and large bowel microbial ecology of 
healthy adult cats. 
Materials and Methods 
Animals and diets 
All animal care procedures were approved by the University of Illinois Institutional 
Animal Care and Use Committee before initiation of the experiment.  Eight domestic 
shorthair male cats 2.8 yr of age (4.94 ± 0.3 kg BW) at the start of the study were utilized.  
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All cats were individually housed in stainless steel cages in a temperature controlled room 
with a 16 h light: 8 h dark cycle.  Food offered and refused was weighed daily to assess food 
intake.  Body weight and body condition score were determined weekly. 
Extruded kibble diets were formulated using oligosaccharide-free ingredients, 
including poultry by-product meal, brewers rice, and poultry fat (Table 1).  The diets were 
extruded at Kansas State University’s Bioprocessing and Industrial Value-Added Program 
Facility (Manhattan, KS) under the direction of Pet Food and Ingredient Technology, Inc. 
(Topeka, KS).  Short-chain fructooligosaccharides (NutraFlora
®
 P-95 short-chain 
fructooligosaccharides, GTC Nutrition, Golden, CO 80401) and GOS (Purimune
TM
 
galactooligosaccharides, GTC Nutrition, Golden, CO 80401) supplementation were included 
in the diet prior to extrusion in exchange for cellulose.  Four diets were prepared: 
1) Control (30% protein, 20% fat, 4% solka floc as the fiber source) 
2) Control + 0.5% scFOS + 3.5% solka floc 
3) Control + 0.5% GOS + 3.5% solka floc 
4) Control + 0.5% scFOS + 0.5% GOS + 3% solka floc 
Experimental design 
A replicated 4x4 Latin square with 21-d periods was used.  Cats were adapted to the 
diet for 14-d, followed by a 7-d total fecal collection phase.  Total feces were collected, 
scored, weighed, and frozen at -20°C until further analysis.  During the 7-d collection phase, 
one fresh fecal sample was collected within 15 min of defecation for measurement of pH, 
DM, protein catabolites, and microbiota enumeration.  All fecal samples were scored for 
consistency based on the following scale: 1 = hard, dry pellets, small hard mass; 2 = hard, 
formed stool that remains firm; 3 = soft, formed, and moist stool that retains its shape;         
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4 = soft, unformed stool that assumes the shape of the container; and 5 = watery, liquid stool 
that can be poured. 
Sample handling 
Fecal samples were dried at 55°C in a forced-air oven.  Diets and dried feces were 
ground through a 2 mm screen in a Wiley mill (Model#4, Thomas Scientific, Swedesboro, 
NJ).  On d 15 of each period, one fresh fecal sample was collected during the 7-d collection 
phase within 15 min of defecation and an aliquot was immediately transferred into sterile 
cryogenic vials (Nalgene, Rochester, NY), snap-frozen in liquid nitrogen, and frozen at        
-80°C until DNA extraction.  Additional aliquots for phenol, indole, and biogenic amine 
analyses were frozen at -20°C immediately following collection.  Additional aliquots for 
ammonia, short-chain fatty acid, and branched-chain fatty acid determinations were put in 5 
ml of 2 N hydrochloric acid and stored at -20°C.  Remaining fecal samples were frozen at     
-20°C. 
Chemical analyses 
Diets and feces were analyzed for DM, organic matter (OM), and ash (AOAC, 
2000).  Crude protein was determined according to AOAC (2000) using a Leco 
Nitrogen/Protein Determinator (model FP-2000, Leco Corporation, St. Joseph, MI).  Fat 
concentration was determined by acid hydrolysis (AACC, 1983) followed by ether 
extraction (Budde, 1952).  Total dietary fiber was determined according to Prosky et al. 
(1984, 1992).  Gross energy was analyzed by use of an oxygen bomb calorimeter (Model 
1261, Parr Instrument, Moline, IL).  Short-chain and branched-chain fatty acid 
concentrations were determined by gas chromatography (Erwin et al., 1961) using a 
Hewlett-Packard 5890A series II gas chromatograph (Palo Alto, CA) and a glass column 
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(180 cm x 4 mm i.d.) packed with 10% SP-1200/1% H3PO4 on 80/100+ mesh Chromosorb 
WAW (Supelco Inc., Bellefonte, PA).  Nitrogen was the carrier with a flow rate of 75 
mL/min.  Oven, detector, and injector temperatures were 125, 175, and 180°C, respectively.  
Fecal ammonia concentrations were determined using spectrophotometry according to 
methods of Chaney and Marbach (1962).  Phenol and indole concentrations were measured 
using gas chromatography according to methods described by Flickinger et al. (2003).  
Biogenic amine concentrations were measured by HPLC according to the methods described 
by Flickinger et al. (2003).   
Microbial analyses 
Fecal microbial populations were analyzed using the method described by Middelbos 
et al. (2007b).  Briefly, total DNA was extracted from fresh fecal samples that had been 
stored at  –80°C using the bead beater method (Yu and Morrison, 2004) followed by a 
QIAamp DNA stool mini kit (Qiagen, Valencia, CA) according to manufacturer’s 
instructions.  Quantity and quality of DNA was determined using a NanoDrop ND-1000 
spectrophotometer (NanoDrop Technologies, Wilmington, DE).  Quantitative PCR was 
performed for determination of Bifidobacterium spp., Lactobacillus spp., Escherichia coli, 
and Clostridium perfringens.  Specific primers, previously used in our laboratory, were used 
for Bifidobacterium spp. (Matsuki et al., 2002), Lactobacillus spp. (Collier et al., 2003), E. 
coli (Malinen et al., 2003), and C. perfringens (Wang et al., 1994).  Briefly, a 10-μL final 
volume contained 5 μL of 2 x SYBR Green PCR Master Mix (Applied Biosystems, Foster 
City, CA), 15 pmol of the forward and reverse primers for the bacterium of interest, and 10 
ng of extracted fecal DNA.  Standard curves were obtained by harvesting pure cultures of 
the bacterium of interest in the log growth phase in triplicate, followed by serial dilution.  
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Bacterial DNA was extracted from each dilution using a QIAamp DNA stool mini-kit and 
amplified with the fecal DNA to create triplicate standard curves using an ABI PRISM 
7900HT Sequence Detection System (Applied Biosystems).  Colony-forming units in each 
dilution were determined by plating on specific agars; lactobacilli MRS (Difco) for 
lactobacilli, reinforced clostridial medium (Bifidobacterium spp., C. perfringens), and Luria 
Bertani medium (E. coli).  The calculated log cfu/ml of each serial dilution was plotted 
against the cycle threshold to create a linear equation to calculate cfu/g dry feces. 
Complete blood count 
A complete blood count (CBC) was determined for each cat on d 21 of each period.  
Approximately 2 ml of blood was taken from the femoral vein and placed into 2.5 ml EDTA 
tubes for CBC analysis at the University of Illinois College of Veterinary Medicine 
Veterinary Diagnostic Lab. 
Calculations  
 Apparent total tract nutrient digestibilities were calculated as nutrient intake (g/d) 
minus fecal nutrient output (g/d); this value then was divided by nutrient intake (g/d) and 
multiplied by 100%.  Metabolizable energy (kcal/g) was calculated on a DM basis using the 
following equation (AAFCO, 2009): [(14.64 x % crude protein) + (35.56 x % acid 
hydrolyzed fat) + (14.6% carbohydrate)]/100, where carbohydrate is equal to 100 – (% ash) 
– (% crude protein) – (% acid hydrolyzed fat) – (% total dietary fiber). 
Statistical analysis 
 The continuous variable data were analyzed by the MIXED procedure (SAS Inst., 
Cary, NC).  For the statistical model, the random effects were animal and period, whereas 
the fixed effect was treatment.  Least squares means were separated using least squares 
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differences with a Tukey adjustment.  A single degree of freedom contrast was conducted to 
test the effect of supplementation treatments (average of three prebiotic supplemented diets) 
compared with the control treatment.  Outlier data were removed from analysis after 
analyzing data using the UNIVARIATE procedure to produce a normal probability plot 
based on residual data and visual inspection of the raw data.  Outlier data were defined as 
data points three or more standard deviations from the mean.  Differences among treatment 
level least squares means with a probability of P ≤ 0.05 were accepted as statistically 
significant, whereas mean differences with P-values ranging from 0.06 to 0.10 were 
accepted as trends. 
Results 
Chemical composition of diets 
The chemical composition of the diets is presented in Table 2.  Analyzed DM, OM, 
and GE concentrations, and calculated ME values, were similar among dietary treatments.  
Analyzed crude protein and acid hydrolyzed fat concentrations were close to the desired 30 
and 20% values, respectively (as-is basis).  The TDF assay cannot quantify scFOS and GOS 
because these oligosaccharides do not precipitate in 78% ethanol.  Therefore, the TDF 
values for scFOS-, GOS-, and scFOS+GOS-supplemented diets were lower than for the 
control diet.  Corrected TDF values (uncorrected TDF values + amount of oligosaccharide 
added to each treatment) were similar among diets (Table 2). 
Food intake and apparent total tract nutrient digestibility 
Food (as-is) and DM intake, fecal output and DM concentration, and apparent total 
tract nutrient digestibilities are presented in Table 3.  Food intake, DM intake, fecal output 
and fecal DM concentration were not different among treatments; however, fecal output 
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tended (P = 0.08) to be greater for cats fed the scFOS+GOS treatment compared to the GOS 
treatment.  Dry matter, OM, acid hydrolyzed fat, and GE digestibilities were similar among 
treatments.  Crude protein digestibility was decreased (P < 0.05) when cats consumed the 
scFOS+GOS treatment compared to those fed the other treatments.  Total dietary fiber 
digestibility is not reported because of the problem mentioned above with oligosaccharide 
quantification. 
Fecal characteristics and fermentation metabolites 
Fecal pH, score, and concentrations of ammonia, 4-methylphenol, and indole are 
presented in Table 4.  Fecal score was not different among treatments.  Fecal pH was 
decreased (P < 0.05) when cats were fed the scFOS+GOS treatment compared to the control 
and GOS treatments.  Fecal pH was decreased (P = 0.05) when scFOS and (or) GOS were 
supplemented compared to the control.  Fecal concentrations of ammonia, 4-methylphenol, 
and indole were not different among treatments. 
Fecal SCFA and BCFA concentrations are presented in Table 5.  Fecal 
concentrations of acetate were greater when cats consumed the scFOS+GOS treatment 
compared to the GOS (P = 0.05) and control (P = 0.10) treatments.  Fecal concentrations of 
butyrate were greater (P = 0.05) for cats consuming the scFOS+GOS treatment compared to 
the control treatment.  Fecal butyrate concentrations tended (P = 0.10) to be greater when 
cats were fed the scFOS and (or) GOS treatments compared to the control.  Fecal 
concentrations of total SCFA tended (P = 0.06) to be greater when cats consumed the 
scFOS+GOS treatment compared to control and GOS treatments.  Fecal concentrations of 
valerate were greater (P < 0.05) for cats fed the scFOS+GOS treatment compared to the 
control and scFOS treatments.  Fecal valerate concentrations tended (P = 0.08) to be greater 
 44 
 
when cats were fed the scFOS and (or) GOS treatments compared to the control.  Fecal 
concentrations of total BCFA tended (P = 0.06) to be greater when cats were fed the 
scFOS+GOS treatment compared to the control.  Fecal propionate, isobutyrate, and 
isovalerate concentrations were not different among treatments.   
Fecal biogenic amine concentrations are presented in Table 6.  Most fecal biogenic 
amine concentrations were not different among treatments; however, fecal tyramine 
concentration tended (P = 0.07) to be lower when cats consumed the scFOS+GOS treatment 
compared to the control treatment.  Fecal tyramine concentrations tended (P = 0.06) to be 
lower when cats were fed the scFOS and (or) GOS treatments compared to the control. 
Fecal microbiota  
 Fecal concentrations of select microbiota are presented in Table 7.  Fecal 
Bifidobacterium spp. concentrations were highest (P < 0.05) in the scFOS+GOS treatment.  
Fecal concentrations of Bifidobacterium spp. were greater (P < 0.05) when cats were fed the 
scFOS and (or) GOS treatments compared to the control.  Fecal concentrations of 
Lactobacillus spp., E. coli, and Clostridium perfringens were not different among 
treatments.  
Complete blood count 
 White blood cell counts are presented in Table 8.  There were no significant 
differences in neutrophils or total white blood cells concentrations among treatments, 
whereas blood lymphocyte concentrations (expressed as a percentage) tended (P = 0.10) to 
be lower for cats fed the scFOS treatment compared to those fed the control.  However, the 
concentrations (expressed as a percentage) of lymphocytes were lower (P < 0.05) when 
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scFOS and (or) GOS were supplemented to cats compared to the control, whereas neutrophil 
concentrations were greater (P = 0.05).  
Discussion 
 A diet was formulated that was free of endogenous oligosaccharides, but was of high 
nutritive value.  Solka floc was used as the control fiber as it is essentially inert and not 
subject to microbial fermentation.  Test oligosaccharides were added to the diet at the 0.5% 
level at the expense of cellulose.  A mixture of the two also was tested at the 0.5% level for 
each, resulting in an experimental treatment containing 1% oligosaccharide.  This was done 
to test the potential synergies between the two oligosaccharides at the same concentrations 
as when fed individually, and to evaluate whether a higher dietary concentration might exert 
a stronger response on the outcome variables measured. 
Dietary composition was similar among diets except for TDF.  As expected, the 
differences in TDF were observed because the scFOS and GOS (alone and in combination) 
do not precipitate in 78% ethanol; therefore, they are unable to be quantified accurately 
using the TDF method.  However, when TDF values were corrected for supplemental test 
prebiotics, values were similar among treatments. 
Dry matter, OM, acid hydrolyzed fat, and GE apparent total tract digestibility values 
were not different among treatments; however, crude protein digestibility decreased (P < 
0.05) with 1% scFOS+GOS supplementation, likely due to the production of greater 
bacterial biomass in the large bowel.  This occurred only at the 1% supplementation level, 
indicating an effect of oligosaccharide concentration and not of individual oligosaccharides 
supplemented at lower dietary concentrations.  This was supported by the increased fecal 
output data noted for the combination treatment. 
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Hesta et al. (2001) reported that cats fed inulin (3 and 6%)- or 3% oligofructose-
supplemented diets had lower total tract crude protein digestibility values.  However, after 
correcting the value for fecal bacterial nitrogen content, crude protein digestibility was not 
different among treatments.  Barry et al. (2009) reported that total tract crude protein 
digestibility tended (P < 0.10) to be linearly increased for dogs supplemented with 0.2% or 
0.4% inulin; however, values were not affected by 0.2 or 0.4% scFOS supplementation. 
As expected, fecal DM content and score were not affected by dietary treatments.  
Barry et al. (2010) found that fecal DM was not affected in cats fed a 4% oligofructose-
supplemented diet.  In dogs, Barry et al. (2009) reported that low level inclusion (0.2 and 
0.4%) of scFOS or inulin did not affect fecal quality.  In the present experiment, fecal output 
tended to be greater in cats fed the scFOS+GOS-supplemented diet compared to the GOS 
diet.  Hesta et al. (2005) noted that cats supplemented with 3.11% oligofructose tended to 
have a greater fecal moisture and output compared to the control. 
Fecal pH was lower when cats were fed the scFOS+GOS treatment compared to the 
control and GOS treatments.  Lower fecal pH likely resulted from lactic acid and SCFA 
production from carbohydrate fermentation.  Hesta et al. (2001) reported that cats fed a 6 or 
9% oligofructose-supplemented diet had lower fecal pH compared to the control and 3% 
oligofructose treatments. 
Fecal ammonia concentrations were not different among treatments.  Similar results 
were observed by Flickinger et al. (2003) when dogs were supplemented with scFOS at 0.5, 
1.5, or 3% dietary concentrations, and by Barry et al. (2009) when dogs were supplemented 
with inulin or scFOS (0.2 and 0.4%). 
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Phenolic and indolic compounds are produced from aromatic amino acid 
(phenylalanine, tyrosine, and tryptophan) fermentation (Blachier et al., 2007).  In the present 
study, only 4-methylphenol and indole were present in all fecal samples. The dietary 
treatments did not affect fecal concentration of phenol or indole.  Flickinger et al. (2003) 
reported that phenol and indole were not affected by 1, 2, or 3 g/d scFOS supplementation in 
dogs.  In contrast, Terada et al. (1993) noted that fecal ethylphenol and indole concentrations 
were significantly decreased in cats supplemented a 175 mg lactosucrose/d.  Potentially 
pathogenic bacteria, including Clostridium perfringens and E. coli, are responsible for the 
production of putrefactive compounds.  In the present study, fecal populations of C. 
perfringens and E. coli were not affected by oligosaccharide inclusion in diets.  This might 
explain, in part, why fecal concentrations of phenol and indole were unaffected by dietary 
oligosaccharide inclusion. 
Fecal acetate concentrations were greater when cats were fed the scFOS+GOS 
compared to the GOS (P < 0.05) and control (P = 0.10) treatments.  Propst et al. (2003) 
reported that fecal acetate concentrations were increased when dogs consumed an 
oligofructose-supplemented diet (0.3, 0.6, and 0.9%, DM basis).  Fecal lactate and acetate 
production have been shown to decrease pH, leading to development of an unfavorable 
environment for pathogenic bacteria (i.e., C. perfringens and E. coli) (Macfarlane and 
Cumming, 1991).  Fecal butyrate concentrations were greater when cats consumed the 
scFOS+GOS treatment compared to the control.  Similarly, 4% oligofructose 
supplementation increased fecal butyrate concentrations in adult cats (Barry et al., 2010).  
Additionally, Hesta et al. (2001) noted that fecal total SCFA concentrations were greater in 
cats fed a 6% inulin-supplemented diet compared to control cats.  Butyrate serves as an 
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energy source for colonocytes, and high butyrate concentrations are thought to play an 
important role in gut health and colonocyte proliferation (Blottiére et al ., 2003).  In the 
current experiment, scFOS or GOS alone did not affect fecal acetate, propionate, butyrate, or 
total SCFA concentrations.  This lack of difference noted for GOS and scFOS alone appears 
to be a function of the dietary concentration provided.  However, fecal butyrate 
concentrations tended to be greater when cats were fed the scFOS and (or) GOS treatments 
compared to the control.  It appears from the data of the present study that if butyrate 
production is to be enhanced, a concentration between 0.5 and 1% is necessary to elicit this 
response. 
When carbohydrate as a substrate for the microbiota of the large intestine is limiting, 
BCFA are produced.  Short-chain fructooligosaccharides and GOS are rapidly fermented in 
the proximal colon, then peptides and amino acids are fermented by bacteria in the 
transverse and distal colon to provide energy.  End-products of amino acid fermentation are 
BCFA, phenol, indole, and biogenic amines.  Branched-chain fatty acids are generated from 
branched-chain amino acids (valine, leucine, and isoleucine) fermentation (Macfarlane et al., 
1992).  In the present experiment, the combination treatment increased fecal concentrations 
of valerate (P < 0.05) and total BCFA (P = 0.06).  Similarly, Barry et al. (2010) noted that 
cats fed 4% oligofructose-supplemented diet had greater fecal concentrations of isobutyrate, 
isovalerate, valerate, and total BCFA compared to cats fed control.  The authors stated that 
these increases might have resulted from the rapid fermentation and absorption of the 
oligosaccharides in the proximal colon; then, proteolytic bacteria in the distal colon would 
continue fermenting amino acids as energy sources instead of carbohydrates. 
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Polyamines including putrescine, spermidine, and spermine, are beneficial protein 
catabolites required for normal development and repair of intestinal mucosal cells (Wang 
and Johnson, 1990).  Löser et al . (1999) noted that rats fed polyamine-deficient diets long-
term had significant hypoplasia of small intestinal and colonic mucosa.  Therefore, a 
decrease in fecal polyamine concentrations may be not desirable.  In the current study, 0.5% 
scFOS or GOS did not affect fecal biogenic amine concentrations except for tyramine that 
tended (P = 0.10) to be lower in cats fed 1% scFOS+GOS compared to control.  Also, Barry 
et al. (2010) noted the fecal tyramine concentrations were significant lower in cats that 
consumed a 4% oligofructose-supplemented diet compared to the control.  Flickinger et al. 
(2003) noted that fecal concentrations of biogenic amines (agmatine, ethylamine, putrescine, 
spermidine, tryptamine, and total amines) were not different when dogs were supplemented 
with 0, 1, 2, or 3 g scFOS/d. 
As expected, scFOS- and GOS-supplemented diets affected fecal microbial 
Bifidobacterium spp. concentrations.  One important criterion to prove oligosaccharide 
efficacy as a prebiotic is selective fermentation by intestinal microbiota increasing beneficial 
bacterial concentrations, including Bifidobacterium spp. and Lactobacillus spp. (Roberfroid, 
2007).  While bifidobacteria populations were increased (P < 0.05), fecal Lactobacillus spp., 
E. coli, and Clostridium perfringens were not affected by dietary treatment.  Terada et al. 
(1993) reported that adult cats supplemented with 175 mg lactosucrose/d had greater fecal 
Bifidobacterium spp. and Lactobacillus spp. and lower fecal Clostridium spp.  
Supplementation with 4% oligofructose significantly increased fecal Bifidobacterium spp. in 
adult cats compared to cellulose (Barry et al., 2010).  Additionally, dogs fed 4 g FOS + 2 g 
MOS (Swanson et al., 2002b) or 1.5% scFOS (Middelbos et al., 2007a) had greater fecal 
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concentrations of Bifidobacterium spp. and Lactobacillus spp. compared to an 
unsupplemented control.  However, low level inclusion of scFOS (0.2 and 0.4%) or inulin 
(0.2 and 0.4%) did not change canine gut microbial populations (Barry et al., 2009). 
White blood cell, neutrophil, and lymphocyte concentrations were generally 
unaffected by dietary treatment.  However, blood lymphocyte concentrations (expressed as a 
percentage) were lower (P = 0.05) in cats fed the scFOS and (or) GOS treatments compared 
to the control, whereas neutrophil concentrations (expressed as a percentage) were greater (P 
< 0.05).  Values remained within the normal physiological range for cats.  Previous studies 
with scFOS, yeast cell wall, or inulin reported inconsistent effects on immunological indices 
among studies, depending on type and concentration of prebiotic (Swanson et al., 2002a, 
2002b; Middelbos et al., 2007a; Barry et al., 2009).  Barry et al. (2009) noted that low level 
inclusion (0.2 and 0.4%) of scFOS and inulin did not affect ileal IgA compared to control.  
Additionally, Middelbos et al. (2007a) reported that there was no significant difference in 
white blood cell counts, ileal IgA, and serum IgA, IgG, and IgM concentrations in dogs fed 
1.5% scFOS or combinations of scFOS + yeast cell wall (1.2% + 0.3% or 0.9% + 0.6%, 
respectively) compared to a 2.5% cellulose control.  The authors stated that greater 
concentrations of oligosaccharide supplementation might be necessary to alter 
immunological indices. 
 Data from this experiment showed positive outcomes of scFOS and GOS on 
nutritional- and health-related characteristics of cats when fed alone or in combination.  The 
effects for the scFOS+GOS treatment likely resulted from the higher concentration provided 
rather than from any synergy that might exist between them.  These oligosaccharides could 
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serve as valuable nutritional interventions to improve digestive health of cats, but it is 
apparent that concentrations > 0.5% should be used to elicit positive responses. 
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Table 1. Ingredient composition of diets containing select carbohydrates and fed to adult cats (as-fed basis). 
 Treatment 
Ingredient, % Control scFOS
1
 GOS
2
 scFOS + GOS 
Poultry by-product, low ash 36.48 36.48 36.48 36.48 
Brewer’s rice 27.76 27.76 27.76 27.76 
Poultry fat 12.00 12.00 12.00 12.00 
Yellow corn, ground 10.00 10.00 10.00 10.00 
Dried egg  5.00 5.00 5.00 5.00 
Solka floc
a
 4.00 3.50 3.50 3.00 
Test carbohydrate
b
 0.00 0.50 0.50 1.00 
Liquid digest 2.00 2.00 2.00 2.00 
Sodium bisulfate 1.00 1.00 1.00 1.00 
Potassium chloride 0.65 0.65 0.65 0.65 
Salt 0.65 0.65 0.65 0.65 
Mineral premix
c
 0.18 0.18 0.18 0.18 
Vitamin premix
d
 0.18 0.18 0.18 0.18 
Taurine supplement
e
 0.10 0.10 0.10 0.10 
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1 
scFOS: short-chain fructooligosaccharides. 
       2 
GOS: galactooligosaccharides. 
       a 
Solka floc: International Fiber Corporation, North Tonawanda, NY 14120. 
       b 
Test carbohydrate: scFOS, NutraFlora
®
 P-95 short-chain fructooligosaccharides, GTC Nutrition, Golden, CO 80401; GOS,      
Purimune
TM
 galactooligosaccharides, GTC Nutrition, Golden, CO 80401. 
       c 
Provided per kilogram of diet: vitamin A, 18 kIU; vitamin D3, 2.7 kIU; vitamin E , 0.144 kIU; vitamin K, 2.16 mg; thiamin, 30.6 mg; 
riboflavin, 30.6 mg; pantothenic acid, 50.4 mg; nicotinic acid, 124.2 mg; pyridoxine, 30.6 mg; biotin, 0.108 mg; folic acid, 1.08 mg; 
vitamin B12, 115 μg. 
  d 
Provided per kilogram of diet: manganese (as MnCO3), 18.0 mg; iron (as C6H8O7.xFe), 135.0 mg; copper (as Cu2(OH)2CO3), 18.0 
mg; zinc (as ZnCO3), 180.0 mg; iodine (as KIO3), 1.8 mg; selenium (as Na2SeO3), 396.0 μg; cobalt (as CoSO4), 3.8 μg. 
       e 
Provided per kilogram of diet: taurine, 2.1 g. 
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Table 2. Chemical composition of extruded cat diets containing select carbohydrates. 
 Treatment 
Item Control scFOS
1
 GOS
2
 scFOS+GOS 
Dry matter, % 95.2 95.0 94.8 95.0 
 ----------------------------------------% DM basis----------------------------------------- 
Organic matter 92.8 92.5 92.4 92.7 
Crude protein 34.6 35.1 35.3 34.0 
Acid hydrolyzed fat 21.2 20.2 20.2 21.1 
Total dietary fiber – uncorrecteda   8.2   7.6   7.8   7.3 
Total dietary fiber – correctedb   8.2   8.1   8.3   8.3 
Gross energy, kcal/g   5.4   5.4   5.5   5.4 
ME
c
, kcal/g (calculated)  4.0  4.0  4.0  4.0 
     
1
scFOS: short-chain fructooligosaccharides. 
     
2 
GOS: galactooligosaccharides. 
        a 
These values were determined using the TDF assay that cannot quantify scFOS and GOS. 
        b 
These values were determined by adding the amount of scFOS and GOS present in each diet to the TDF (uncorrected) value. 
       c 
Metabolizable energy was calculated using the following equation: [(14.64 x % crude protein) + (35.56 x % acid hydrolyzed fat) + 
(14.6% carbohydrate)]/100, where carbohydrate is equal to 100 – (% ash) – (% crude protein) – (% acid hydrolyzed fat) – (% total 
dietary fiber) when all values are expressed on a DM basis (AAFCO, 2009). 
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Table 3. Food intake, dry matter intake, fecal output, fecal dry matter concentration, and nutrient digestibilities for cats supplemented 
with short-chain fructooligosaccharides (scFOS) and (or) galactooligosaccharides (GOS). 
Item 
Treatment 
SEM 
P-value 
Control scFOS GOS scFOS+GOS Main effects 
Control vs. 
supplementation 
Food intake, g/d (as-is) 58.7 
 
58.3 
 
57.6 
 
59.3 
 
0.59 0.16 0.63 
Dry matter intake, g/d 55.9 
 
55.4 
 
54.7 
 
56.3 
 
0.57 0.11 0.49 
Fecal output, g (as-is) 173.1 
cd 
168.0 
cd 
158.9 
d 
183.1 
c 
7.93 0.08 0.67 
Fecal DM, % 43.8  44.4  43.6  41.1  1.44 0.41 0.66 
Apparent total tract digestibility, %     
Dry matter 81.4  81.7  82.7  81.2  0.56 0.25 0.43 
Organic matter 84.4  84.8  85.6  84.4  0.47 0.30 0.36 
Crude protein 84.2 
a 
84.0 
a 
84.7 
a 
81.9 
b 
0.52 0.01 0.28 
Acid hydrolyzed fat 95.7  95.5  95.9  95.5  0.19 0.32 0.78 
Gross energy 85.9  86.2  87.1  85.8  0.42 0.14 0.34 
 
     
a,b
 Values lacking a common superscript letter within each row are different (P ≤ 0.05). 
       c,d  
Values lacking a common superscript letter within each row are different (P ≤ 0.10). 
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Table 4. Fecal pH, score, and concentrations of ammonia, 4-methylphenol, and indole for cats supplemented with short-chain 
fructooligosaccharides (scFOS) and (or) galactooligosaccharides (GOS). 
Item 
Treatment 
SEM 
P-value 
Control scFOS GOS scFOS+GOS Main effects 
Control vs. 
supplementation 
Fecal  
 
 
 
 
 
 
 
  
 
   Score
1
 2.7  2.7  2.7  2.8   0.12 0.81 0.75 
   pH 6.7 
a
 6.4 
ab
 6.6 
a
 6.0 
b
  0.15 0.03 0.05 
Ammonia, µmol/g DM 110.0  125.7  100.6  129.3  11.88 0.16 0.46 
4-Methylphenol, µmol/g DM 2.2  2.3  2.4  2.4  0.36 0.93 0.56 
Indole, µmol/g DM 1.9  1.5  1.8  1.9  0.20 0.28 0.31 
 
     
a,b 
Values lacking a common superscript letter within each row are different (P ≤ 0.05). 
          1
 All fecal samples were scored for consistency based on the following scale: 1 = hard, dry pellets, small hard mass; 2 = hard, formed 
stool that remains firm; 3 = soft, formed, and moist stool that retains its shape; 4 = soft, unformed stool that assumes the shape of the 
container; and 5 = watery, liquid stool that can be poured. 
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Table 5. Fecal short-chain fatty acid (SCFA) and branched-chain fatty acid (BCFA) concentrations for cats supplemented with short-
chain fructooligosaccharides (scFOS) and (or) galactooligosaccharides (GOS). 
Item 
Treatment 
SEM 
P-value 
Control scFOS GOS scFOS+GOS Main effects 
Control vs. 
supplementation 
 --------------------------µmol/g DM-----------------------    
 
Acetate 166.5 
ab
 173.8 
ab
 159.8 
b
 219.4 
a
 15.25 0.05 0.32 
Propionate 51.7  53.1  53.1  68.7  5.90 0.17 0.34 
Butyrate 28.5 
b
 31.4 
ab
 35.4 
ab
 42.4 
a
 3.84 0.05 0.10 
Total SCFA 246.7 
d 
258.4 
cd 
248.3 
d 
330.6 
c 
23.20 0.06 0.24 
Isobutyrate 5.6  5.9  5.6  7.1  0.69 0.15 0.32 
Isovalerate 9.0  9.4  9.3  10.9  1.16 0.41 0.39 
Valerate 16.2 
b
 16.9 
b
 17.5 
ab
 22.3 
a
 1.77 0.01 0.08 
Total BCFA 31.3 
d 
32.8 
cd  
32.4 
cd 
40.9 
c 
3.58 0.06 0.19 
 
     
a,b
 Values lacking a common superscript letter within each row are different (P ≤ 0.05). 
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Table 6. Fecal biogenic amine concentrations for cats supplemented with short-chain fructooligosaccharides (scFOS) and (or) 
galactooligosaccharides (GOS). 
Item 
Treatment 
SEM 
P-value 
Control scFOS GOS scFOS+GOS Main effects 
Control vs. 
supplementation 
 -----------------------------µmol/g DM-----------------------    
 
Cadaverine 266.1  192.2  250.8  219.4  55.55 0.86 0.78 
Putrescine 44.1  36.3  48.2  33.5  8.13 0.57 0.61 
Histamine 11.3  9.8  12.4  14.8  3.34 0.52 0.18 
Tryptamine 20.1  24.1  19.6  45.0  6.68 0.11 0.41 
Tyramine 55.5 
c 
32.9 
cd 
50.4 
cd 
28.0 
d 
8.10 0.07 0.06 
Spermidine 16.3  15.4  18.9  19.4  1.90 0.40 0.48 
Spermine 3.7  4.0  3.1  3.3  1.55 0.78 0.45 
 
     c,d 
Values lacking a common superscript letter within each row are different (P ≤ 0.10). 
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Table 7. Fecal microbial populations for cats supplemented with short-chain fructooligosaccharides (scFOS) and (or) 
galactooligosaccharides (GOS). 
Item 
Treatment 
SEM 
P-value 
Control scFOS GOS scFOS+GOS Main effects 
Control vs. 
Supplementation 
 -------------------CFU log10/g fecal DM-----------------   
 
Bifidobacterium spp. 9.3 
c
 9.8 
b
 10.2 
ab
 10.4 
a
 0.15 0.01 0.01 
Lactobacillus spp. 10.7  10.7  10.8  10.9  0.14 0.27 0.19 
Escherichia coli 10.2  10.5  10.3  10.4  0.14 0.54 0.31 
Clostridium perfringens 9.6  9.6  9.7  9.7  0.19 0.73 0.51 
 
     a,b,c
 Values lacking a common superscript letter within each row are different (P ≤ 0.05). 
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Table 8. White blood cell counts for cats supplemented with short-chain fructooligosaccharides (scFOS) and (or) 
galactooligosaccharides (GOS). 
Item 
Treatment 
SEM 
P-value 
Control scFOS GOS scFOS+GOS Main effects 
Control vs. 
Supplementation 
Total white blood cells, 10
3
/µl 8.2  8.7  8.3  9.1  0.53 0.58 0.41 
Neutrophils, % 52.0  58.5  59.0  56.4  2.67 0.21 0.05 
Neutrophils, 10
3
/µl 4.3 
 
4.9  5.6 
 
4.9  0.50 0.41 0.20 
Lymphocytes, % 39.9 
 
c 
33.3 
 
d 
33.9 
cd 
34.9 
 
cd 
2.75 0.10 0.02 
Lymphocytes, 10
3
/µl 3.1 
 
4.9  5.6 
 
4.9  0.21 0.37 0.21 
 
     c,d 
Values lacking a common superscript letter within each row are different (P ≤ 0.10). 
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